Goldman Sachs’s Spindletop Health Acquisition Corp. Warrant SHCAW Stock Holding History

Goldman Sachs’s Portfolio SHCAW Stock Details SHCAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-101,067	Closed	-$4K	–	6447
2022 Q3	$4K	Hold	101,067	–	–	﹤0.01%	6127
2022 Q2	$8K	Hold	101,067	–	–	﹤0.01%	6295
2022 Q1	$15K	Buy	101,067 +1,067	+1%	+$406	﹤0.01%	6447
2021 Q4	$50K	Buy	+100,000	New	+$55K	﹤0.01%	6269

Goldman Sachs's SHCAW Position: Q4 2022 in Review

Goldman Sachs sold out of Spindletop Health Acquisition Corp. Warrant (SHCAW) in Q4 2022, closing a stake of 101,067 shares — an estimated $4K sold.

Goldman Sachs first reported a position in SHCAW in Q4 2021 and held it in 4 quarters. The position peaked at $50K in Q4 2021. 0 funds tracked by Wall St. Rank hold SHCAW as of Q4 2022.

Goldman Sachs reported no remaining Spindletop Health Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 101,067 Spindletop Health Acquisition Corp. Warrant shares in Q4 2022, an estimated $4K.
Goldman Sachs first reported a position in Spindletop Health Acquisition Corp. Warrant in Q4 2021 and held it in 4 quarters.
Goldman Sachs's Spindletop Health Acquisition Corp. Warrant position peaked at $50K in Q4 2021.
0 funds tracked by Wall St. Rank held Spindletop Health Acquisition Corp. Warrant as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.